Poor performance status (ECOG ≥3): patient capable of only limited self-care, confined to...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-FITNESS-ECOG-POOR |
|---|---|
| Type | Red flag |
| Status | reviewed 2026-04-27 | pending_clinical_signoff |
| Diseases | None declared |
| Sources | SRC-ESMO-DLBCL-2024 SRC-NCCN-BCELL-2025 |
Red Flag Origin
| Definition | Poor performance status (ECOG ≥3): patient capable of only limited self-care, confined to bed/chair >50% of waking hours, or completely disabled. Generally palliative/best-supportive-care intent; cytotoxic therapy at full dose contraindicated. Selective targeted-therapy or steroid debulk may be appropriate as bridge to reassessment. |
|---|---|
| Clinical direction | de-escalate |
| Category | fitness-eligibility |
Trigger Logic
{
"any_of": [
{
"comparator": ">=",
"finding": "ecog",
"threshold": 3
}
],
"type": "composite_score"
}
Notes
ECOG ≥3 routinely excludes patients from cytotoxic intensification trials. Decision is rarely "no treatment" but rather "treatment proportional to the patient's reserve": prednisolone-only debulk for steroid-responsive disease (DLBCL, ALL) to allow reassessment; rituximab-monotherapy for B-cell indolent disease; ibrutinib-monotherapy in CLL/MCL/WM; aza-monotherapy or BSC in elderly AML. Engages palliative-care consult per NCCN Palliative Care guidelines and ESMO supportive-care guidance. ECOG ≥3 caused by disease itself (e.g. DLBCL with massive disease) may improve dramatically with steroid pre-phase — reassess after 3-7 days.
Used By
Indications
IND-GI-NET-ADVANCED-1L-LANREOTIDE- IND-GI-NET-ADVANCED-1L-LANREOTIDEIND-PNET-METASTATIC-1L-EVEROLIMUS- IND-PNET-METASTATIC-1L-EVEROLIMUS
Red flag
RF-FRAILTY-AGE-G8-LOW- Geriatric vulnerability flag: age ≥75 AND G8 screening score ≤14 (out of 17 max). Trigger...